跳至主要内容
临床试验/NCT07262710
NCT07262710尚未招募不适用

Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine0 个研究点目标入组 13,656 人开始时间: 2025年12月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
13,656
主要终点
Occurrence of post-stroke pneumonia

研究概览

简要总结

The goal of this retrospective cohort study is to determine if Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs) can lower the risk of post-stroke pneumonia. With an active comparator, new-user design, we selected new users of Calcium Channel Blockers (CCBs) as the reference group to compare against new users of ACEIs/ARBs.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of both stroke and hypertension, with the initial diagnosis dates for both conditions falling within the period from January 1, 2016, to December 31, 2024.Definition of Stroke: International Classification of Diseases, 10th Revision (ICD-10) codes I60-I64, or a primary diagnosis of stroke-related conditions in inpatient/outpatient medical records, including but not limited to: cerebral hemorrhage, hemorrhagic stroke, cerebral infarction, ischemic stroke, cerebral ischemia, brainstem infarction.Definition of Hypertension: ICD-10 code I10, or inpatient/outpatient medical records containing diagnostic names such as hypertension, benign hypertension, hypertensive crisis.
  • At least one prescription filled from any of the five major classes of antihypertensive medications: Angiotensin-Converting Enzyme Inhibitors (ACEI), Angiotensin II Receptor Blockers (ARB), Beta-blockers, Calcium Channel Blockers (CCB), or Diuretics. Furthermore, there must be no record of any ACEI, ARB, or CCB prescriptions within the 12 months immediately preceding the first ACEI, ARB, or CCB prescription.
  • Aage ≥18 years.

排除标准

  • Data anomalies or errors(such as an inaccurately recorded date of death).
  • Concurrent use of two or three drug classes among ACEI, ARB, and CCB at any time.
  • Any recorded diagnosis of pneumonia prior to the initiation of the first antihypertensive medication.Definition of Pneumonia: ICD-10 codes J12-J18 or J69, or inpatient/outpatient medical records containing diagnostic names such as pulmonary infection, pneumonia, lung infection.

研究组 & 干预措施

ACEI-exposed group

Newly Initiated ACEI

干预措施: angiotensin converting enzyme inhibitors (Drug)

ARB-exposed group

Newly Initiated ARB

干预措施: Angiotensin Receptor Blockers (Drug)

CCB-exposed group1

Newly Initiated CCB

干预措施: Calcium Channel Blockers (Drug)

CCB-exposed group2

Newly Initiated CCB

干预措施: Calcium Channel Blockers (Drug)

结局指标

主要结局

Occurrence of post-stroke pneumonia

时间窗: The follow-up end point was defined as the earliest occurrence of any of the following events: a diagnosis of pneumonia, death, the date of the last available medical record in the database, or the end of the study period (December 31, 2024).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiaonong Fan

Chief physician

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

相似试验

进行中(未招募)
1 期
Angiotensin Converting Enzyme Inhibitor (ACE) Induced AngioedemaBERINERTRandomized, double-blind, two arms, multicenter, Phase III study of Berinert for treatment of ACE induced AngioedemaAngiotensin – Converting – Enzyme – Inhibitors (ACEi) are used in the treatment of several types of cardiovascular and renal diseases. A known side effect of ACEi are angioedema of the head and neck region. These can lead to severe dyspnoea and the need for intubation and are thought to be bradykinin mediated. Up until now there is no study-evaluated conservative therapeutic concept for the treatment of these patients.MedDRA version: 18.1Level: HLTClassification code 10002425Term: AngioedemasSystem Organ Class: 100000004870
EUCTR2012-001670-28-DEMedizinische Fakultät der Technischen Universität München52
已完成
不适用
Angiotensin Converting Enzyme (ACE) inhibitors in renal transplant recipients with left ventricular hypertrophy
ISRCTN94487168Azienda Ospedaliera Universitaria S.Martino (Italy)70
已完成
不适用
Angiotensin converting enzyme (ACE) inhibition and mechanisms of skeletal muscle weakness in chronic obstructive pulmonary disease (COPD)
ISRCTN05581879Imperial College London (UK)80
已完成
不适用
Angiotensin Converting Enzyme (ACE) inhibition for the preservation of renal function and patient survival in kidney transplantatioChronic kidney disease in renal transplant patientsUrological and Genital DiseasesChronic kidney disease
ISRCTN78129473Ottawa Hospital Research Institute (OHRI) (Canada) - formerly Ottawa Health Research Institute528
已完成
不适用
Effect of angiotensin-converting enzyme inhibitors on systemic inflammation and myocardial sympathetic innervation in normotensive patients with type two diabetes mellitusType two Diabetes Mellitus (DM)Nutritional, Metabolic, EndocrineDiabetes mellitus
ISRCTN76608550Heraklion University Hospital (Greece)62